"However, information related to pregnancy appears in Section 8.1 and 8.3 of the prescribing information for both Ozempic and Wegovy." "I don't believe that we're going to see hideous long-term side effects but who wants to take the chance?" That information includes the following warning: "Based on animal reproduction studies, there may be potential risks to the fetus from exposure to semaglutide during pregnancy, [Ozempic and Wegovy] should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus." Said the company, "Pregnant women exposed to [Ozempic and Wegovy] and health care providers are encouraged to contact Novo Nordisk at 1-800-727-6500." Novo Nordisk also pointed out that while Wegovy and Ozempic both contain semaglutide, they are different products with different indications, dosages, prescribing information, titration schedules and delivery devices

SAT-140 A Drug-Drug Interaction Trial of Oral Semaglutide with Levothyroxine and Multiple Coadministered Tablets
Accelerate Your Metabolism With Incivra Safety and Side Effects at Different Doses Of Retatrutide As with other incretin-based therapies, the side effects of Retatrutide are closely tied to dose and rate of titration
E11.9 Type 2 diabetes mellitus without complications Use when: The patient has Type 2 diabetes without complications, and Ozempic is prescribed for glycemic control
Individual neurological vulnerability